Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to antibody or antibody fragment or immunoglobulin;...
Reexamination Certificate
2008-07-03
2010-10-05
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to antibody or antibody fragment or immunoglobulin;...
C424S001110, C424S001650, C424S130100, C424S178100, C206S223000, C206S569000, C206S570000
Reexamination Certificate
active
07807133
ABSTRACT:
Dimers of avidin and streptavidins (diavidins) are described wherein the linker is suberate, which in turn, is bound to different functional groups (—NH2 o-COOH) of avidin. As compared to avidin, the diavidins have shown the ability to increase the amount of labelled biotin on the target, when used in an in vitro pretargeting test using supported human tenascin, the biotinylated anti-tenascin monoclonal antibody (Mab-B), avidin/diavidin, and biotin-3H. The use of such diavidins is also described in cancer diagnosis and anticancer therapy based on the three-step pretargeted radioimmunotherapy procedure.
REFERENCES:
patent: 4687732 (1987-08-01), Ward et al.
patent: 5482698 (1996-01-01), Griffiths
patent: 5630996 (1997-05-01), Reno et al.
patent: 7425317 (2008-09-01), De Santis et al.
patent: 2005/0106102 (2005-05-01), De Santis et al.
Chinol et al. “Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity” Brit. J. Cancer 78:189-197 (1998).
Chinol et al. “Biodistribution in tumour-bearing mice of two 90Y-labelled biotins using three-step tumour targeting” Nucl. Med. Comm. 18:176-182 (1997).
Cremonesi et al. “Three-step radioimmunotherapy with Yttrium-90 biotin: Dosimetry and pharmacokinetics in cancer patients” Eur. J. Nucl. Med. 26:110-120 (1999).
Hart et al. “HPMA copolymer-modified avidin: Immune response” J. Biomaterials Sci. 11:1-12 (2000).
Reznik et al. “Streptavidins with intersubunit crosslinks have enhanced stability” Nat. Biotechnol. 14:1007-1011 (1998).
International Search Report for PCT/IT03/00135 dated Oct. 7, 2003.
Carlo Antonio Nuzzolo
Ragnar Lindstedt
Rita De Santis
Jones D L
Lucas & Mercanti LLP
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
Avidin dimers effective in increasing the concentration of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Avidin dimers effective in increasing the concentration of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Avidin dimers effective in increasing the concentration of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4165619